← Back to Search

Mouth closed for Sleep Hypopnea

N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day - the intervention of mouth closure is applied acutely on alternating breaths, such that the effect of mouth closure on the outcome is assessed based on the experiment which occurs in a single day.
Awards & highlights

Summary

Mouth breathing is associated with increased airway resistance, pharyngeal collapsibility, and obstructive sleep apnea (OSA) severity. It is commonly believed that closing the mouth can mitigate the negative effects of mouth breathing during sleep. However, we propose that mouth breathing serves as an essential route bypassing obstruction along the nasal route (e.g., velopharynx). The present study investigates the role of mouth breathing as an essential route in some OSA patients and its association with upper airway anatomical factors. Participants underwent drug-induced sleep endoscopy (DISE) with simultaneous pneumotach airflow measurements through the nose and mouth separately. During the DISE procedure, alternating mouth closure (every other breath) cycles were performed during flow-limited breathing. We evaluated the overall effect mouth closure on inspiratory airflow, and the change in inspiratory airflow with mouth closure across three mouth-breathing quantiles. We also evaluated if velopharyngeal obstruction was associated with mouth breathing and a negative airflow response to mouth closure.

Eligible Conditions
  • Sleep Hypopnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day - the intervention of mouth closure on the outcome is applied acutely on alternating breaths, such that the effect of mouth closure is assessed based on the experiment which occurs in a single day.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day - the intervention of mouth closure on the outcome is applied acutely on alternating breaths, such that the effect of mouth closure is assessed based on the experiment which occurs in a single day. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Total inspiratory flow
Secondary study objectives
Change in total inspiratory airflow with mouth closure

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mouth closedExperimental Treatment1 Intervention
Closing the mouth by applying pressure to the mentum until the teeth were in occlusion, without altering the head position. Performed during flow-limited breathing.
Group II: Mouth relaxedActive Control1 Intervention
Mouth in the natural relaxed position during sleep.

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,834,215 Total Patients Enrolled
Brigham and Women's HospitalLead Sponsor
1,653 Previous Clinical Trials
11,490,969 Total Patients Enrolled
Massachusetts Eye and Ear InfirmaryOTHER
108 Previous Clinical Trials
12,968 Total Patients Enrolled
~18 spots leftby Sep 2025